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Ethical concerns surrounding the conception of
an HLA compatible child for medical purposes 
In an interesting article published in the editorial of
Haematologica, Burgio et al. recall the touching case of a
couple that gave natural birth to a child in an attempt to
save the life of their daughter affected by Philadelphia-pos-
itive chronic myeloid leukemia.1 The new baby was HLA-
compatible and hematopoietic stem cell transplantation
took place when he was 19 months old (3 April 1987). The
article to which we refer explains very clearly that there
are currently at least two possibilities for planning the con-
ception of a savior child. The first is by natural procreation,
as in the case above; the second takes into consideration “a
full blown and technically perfect Pre-implantation
Genetic Diagnosis (PGD) program which brings into the
world a child who satisfies the two requirements needed
to save the elder sibling’s life: a healthy child who is HLA-
compatible”. The authors consider it unwise to opt for a
normal, natural birth.1
In our opinion, even the second option could prove to be
a problematic ethical choice. To explain our point of view,
we need to make a fundamental premise: having a baby is
not an automatic right. No human life can be justified
because it gives rights to another human being. The use of
an in vitro fertilization (IVF) technique for the generation of
a savior child transforms the possibility or the desire to
have a baby into the right to have a baby. This is not the
case of natural birth. Although the intention may be the
same with both methods (we are not judging the parents’
decision), the uncertainty of the result in natural childbirth
is Nature's way of reminding us that no one can choose his
or her baby. 
The second and perhaps most dramatic argument from
an ethical point of view, takes into account the possibility
of selecting the right savior embryo while discharging the
unhealthy or unwelcome one. The possibilities opened up
by PGD bring us directly to the problem of the ontological
status of the embryo. In 1996, the Italian National Board
of Bioethics stated that “the fundamental respect for the
human being is due from the beginning, then every exper-
imentation or manipulation are ethically unacceptable.
The only allowed intervention on the embryo must have
therapeutic purpose”.2 The meaning of this statement is
that the embryo must be considered a human being from
the very beginning. There is abundant scientific evidence
to support this view. In fact, from the zygote stage
onward, the human embryo has a coordinate, continuous,
gradual development and there is not a stage where we
can indicate substantial transformation. Therefore, it
becomes mandatory to consider the embryo a human
being, worthy of protection and moral respect.2-4 The
human embryo is a human being. If this is true, as we believe
it is, the logical consequence is that we cannot suppress a
human being, not even to save another human being, nor
can we choose to save a healthy HLA-compatible embryo
thereby suppressing the others.  Contrary to the opinion
expressed by the authors in their article, we do not consid-
er the combination of IVF and PGD the best way to obtain
a compatible donor for transplantation. If we balance the
pros and cons, we find that the decision to have a baby by
natural birth is the best way to respect the dignity of all the
human beings involved and, at the same time, to try and
save someone else’s life. Of course, we are aware that this
approach offers no guarantees, but we prefer an uncertain
result that fully respects human rights rather than a secure
outcome that violates the fundamental right of every
human being: the right to live.
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